1112 related articles for article (PubMed ID: 25470391)
1. Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders.
Slyepchenko A; Carvalho AF; Cha DS; Kasper S; McIntyre RS
CNS Neurol Disord Drug Targets; 2014; 13(10):1770-86. PubMed ID: 25470391
[TBL] [Abstract][Full Text] [Related]
2. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
Kim YK; Shin C
Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886
[TBL] [Abstract][Full Text] [Related]
3. From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders.
Zagórska A; Marcinkowska M; Jamrozik M; Wiśniowska B; Paśko P
Benef Microbes; 2020 Dec; 11(8):717-732. PubMed ID: 33191776
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Connection Between the Gut-Brain Axis and Stress/Anxiety Disorders.
Lee Y; Kim YK
Curr Psychiatry Rep; 2021 Mar; 23(5):22. PubMed ID: 33712947
[TBL] [Abstract][Full Text] [Related]
5. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
[TBL] [Abstract][Full Text] [Related]
6. Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.
Radford-Smith DE; Anthony DC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111100
[TBL] [Abstract][Full Text] [Related]
7. Probiotics supplementation in prophylaxis and treatment of depressive and anxiety disorders - a review of current research.
Herman A
Psychiatr Pol; 2019 Apr; 53(2):459-473. PubMed ID: 31317970
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
9. Effects of Microbiota Imbalance in Anxiety and Eating Disorders: Probiotics as Novel Therapeutic Approaches.
Navarro-Tapia E; Almeida-Toledano L; Sebastiani G; Serra-Delgado M; García-Algar Ó; Andreu-Fernández V
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652962
[TBL] [Abstract][Full Text] [Related]
10. Man and the Microbiome: A New Theory of Everything?
Butler MI; Cryan JF; Dinan TG
Annu Rev Clin Psychol; 2019 May; 15():371-398. PubMed ID: 30786244
[TBL] [Abstract][Full Text] [Related]
11. Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms.
Chahwan B; Kwan S; Isik A; van Hemert S; Burke C; Roberts L
J Affect Disord; 2019 Jun; 253():317-326. PubMed ID: 31078831
[TBL] [Abstract][Full Text] [Related]
12. One Giant Leap from Mouse to Man: The Microbiota-Gut-Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials.
Forssten SD; Ouwehand AC; Griffin SM; Patterson E
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276927
[TBL] [Abstract][Full Text] [Related]
13. Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner.
Murray E; Sharma R; Smith KB; Mar KD; Barve R; Lukasik M; Pirwani AF; Malette-Guyon E; Lamba S; Thomas BJ; Sadeghi-Emamchaie H; Liang J; Mallet JF; Matar C; Ismail N
Brain Behav Immun; 2019 Oct; 81():198-212. PubMed ID: 31212008
[TBL] [Abstract][Full Text] [Related]
14. The gut-brain relationship: Investigating the effect of multispecies probiotics on anxiety in a randomized placebo-controlled trial of healthy young adults.
Tran N; Zhebrak M; Yacoub C; Pelletier J; Hawley D
J Affect Disord; 2019 Jun; 252():271-277. PubMed ID: 30991255
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?
Park C; Brietzke E; Rosenblat JD; Musial N; Zuckerman H; Ragguett RM; Pan Z; Rong C; Fus D; McIntyre RS
Brain Behav Immun; 2018 Oct; 73():115-124. PubMed ID: 30009996
[TBL] [Abstract][Full Text] [Related]
16. From isoniazid to psychobiotics: the gut microbiome as a new antidepressant target.
Butler MI; Sandhu K; Cryan JF; Dinan TG
Br J Hosp Med (Lond); 2019 Mar; 80(3):139-145. PubMed ID: 30860919
[TBL] [Abstract][Full Text] [Related]
17. Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain-Gut-Microbiome Axis.
Chudzik A; Orzyłowska A; Rola R; Stanisz GJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356624
[TBL] [Abstract][Full Text] [Related]
18. Moody microbiome: Challenges and chances.
Kuo PH; Chung YE
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S42-S54. PubMed ID: 30262220
[TBL] [Abstract][Full Text] [Related]
19. The Microbiota-Gut-Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect.
Zhu F; Tu H; Chen T
Nutrients; 2022 May; 14(10):. PubMed ID: 35631224
[TBL] [Abstract][Full Text] [Related]
20. Probiotics as a Tool for Regulating Molecular Mechanisms in Depression: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Sikorska M; Antosik-Wójcińska AZ; Dominiak M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
